Risk stratification of acute myeloid leukemia
10.3760/cma.j.issn.1009-9921.2017.11.002
- VernacularTitle:急性髓系白血病的危险度分层
- Author:
Suning CHEN
1
;
Linlin WANG
Author Information
1. 215006,苏州大学附属第一医院血液科 江苏省血液病研究所
- Keywords:
Leukemia;
myeloid;
acute;
Prognosis;
Risk stratification
- From:
Journal of Leukemia & Lymphoma
2017;26(11):643-645
- CountryChina
- Language:Chinese
-
Abstract:
Patients with acute myeloid leukemia (AML) present a great heterogeneity in clinical presentation and prognosis, and adequate risk stratification before treatment is particularly important in selecting a rational treatment. In addition, a standardized dynamic minimal residual disease (MRD) analysis during treatment will improve early prediction of leukemia relapse and timely intervention. In addition to routine prognostic stratification, newly discovered molecular markers in recent years provide new effective markers for risk stratification and MRD monitoring of AML.
